MENU
KYMR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kymera Therapeutics (KYMR) Ownership - Who owns Kymera Therapeutics?

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives... Show more

Profile

Industry
N/A
Address
500 North Beacon Street
Phone
+1 857 285-5300
Employees
238
Web
https://www.kymeratx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
7.19B
P/E Ratio
N/A
Total Cash
650.93M
Projected Growth
N/A
Total Debt
80.47M
Revenue
51.48M
Risk (Beta)
2.34
Dividend Yield
N/A
Total Cash/Share
7.91
Total Debt/Equity
N/A
Revenue/Share
0.58 USD as % of share price
View a ticker or compare two or three
KYMR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile
Details
Industry
N/A
Address
500 North Beacon Street
Phone
+1 857 285-5300
Employees
238
Web
https://www.kymeratx.com